Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilma Knol

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Drugs & Aging|December 8, 2021
Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and MultimorbidityBastiaan T G M Sallevelt, Corlina J A Huibers, Jody M J Op Heij, et al.
Journal of the American Geriatrics Society|July 28, 2021
Interventions for preventing falls and fall-related fractures in community-dwelling older adults: A systematic review and network meta-analysisLauren Dautzenberg, Shanthi Beglinger, Sofia Tsokani, et al.
British Journal of Clinical Pharmacology|June 18, 2022
Do we become better prescribers after graduation: A 1-year international follow-up study among junior doctorsErik M Donker, David J Brinkman, Floor van Rosse, et al.
European Journal of Clinical Pharmacology|September 22, 2023
The impact of a summative national prescribing assessment and curriculum type on the development of the prescribing competence of junior doctorsErik M Donker, Hayaudin Osmani, David J Brinkman, et al.
The Lancet. Healthy Longevity|November 17, 2023
Inclusion of functional measures and frailty in the development and evaluation of medicines for older adultsMichael Denkinger, Wilma Knol, Antonio Cherubini, et al.
European Geriatric Medicine|July 29, 2020
Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysisKatie Palmer, Emanuele R Villani, Davide L Vetrano, et al.
BMJ Open|June 6, 2019
Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trialLuise Adam, Elisavet Moutzouri, Christine Baumgartner, et al.
Age and Ageing|December 22, 2020
STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing DrugsLotta J Seppala, Mirko Petrovic, Jesper Ryg, et al.
Drugs & Aging|October 25, 2022
A Systematic Review of the Current Evidence from Randomised Controlled Trials on the Impact of Medication Optimisation or Pharmacological Interventions on Quantitative Measures of Cognitive Function in Geriatric PatientsFarhad Pazan, Mirko Petrovic, Antonio Cherubini, et al.
European Journal of Clinical Pharmacology|August 7, 2021
Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trialsFarhad Pazan, Mirko Petrovic, Antonio Cherubini, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Drugs & Aging|December 8, 2021
Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and MultimorbidityBastiaan T G M Sallevelt, Corlina J A Huibers, Jody M J Op Heij, et al.
Journal of the American Geriatrics Society|July 28, 2021
Interventions for preventing falls and fall-related fractures in community-dwelling older adults: A systematic review and network meta-analysisLauren Dautzenberg, Shanthi Beglinger, Sofia Tsokani, et al.
British Journal of Clinical Pharmacology|June 18, 2022
Do we become better prescribers after graduation: A 1-year international follow-up study among junior doctorsErik M Donker, David J Brinkman, Floor van Rosse, et al.
European Journal of Clinical Pharmacology|September 22, 2023
The impact of a summative national prescribing assessment and curriculum type on the development of the prescribing competence of junior doctorsErik M Donker, Hayaudin Osmani, David J Brinkman, et al.
The Lancet. Healthy Longevity|November 17, 2023
Inclusion of functional measures and frailty in the development and evaluation of medicines for older adultsMichael Denkinger, Wilma Knol, Antonio Cherubini, et al.
European Geriatric Medicine|July 29, 2020
Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysisKatie Palmer, Emanuele R Villani, Davide L Vetrano, et al.
BMJ Open|June 6, 2019
Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trialLuise Adam, Elisavet Moutzouri, Christine Baumgartner, et al.
Age and Ageing|December 22, 2020
STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing DrugsLotta J Seppala, Mirko Petrovic, Jesper Ryg, et al.
Drugs & Aging|October 25, 2022
A Systematic Review of the Current Evidence from Randomised Controlled Trials on the Impact of Medication Optimisation or Pharmacological Interventions on Quantitative Measures of Cognitive Function in Geriatric PatientsFarhad Pazan, Mirko Petrovic, Antonio Cherubini, et al.
European Journal of Clinical Pharmacology|August 7, 2021
Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trialsFarhad Pazan, Mirko Petrovic, Antonio Cherubini, et al.
Pageof 10